Aquestive Therapeutics Inc (NAS:AQST)
$ 3.21 -0.06 (-1.83%) Market Cap: 292.23 Mil Enterprise Value: 235.16 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 55/100

Q2 2019 Aquestive Therapeutics Inc Earnings Call Transcript

Aug 07, 2019 / 12:00PM GMT
Release Date Price: $3.52 (+11.75%)
Operator

Good morning, and welcome to the Aquestive Therapeutics Second Quarter Conference Call. (Operator Instructions) As a reminder, this call will be recorded.

I would now like to introduce your host for today's conference, Ms. Lauren Walrath, Head, Corporate Marketing and Communications. You may begin.

Lauren Walrath
Aquestive Therapeutics, Inc. - Head of Corporate Marketing & Communications

Thank you, operator. Good morning, and welcome to today's call to review Aquestive Therapeutics results for the second quarter 2019 and business highlights as well as the top line data from the Libervant crossover study.

On today's call, I am joined by Keith Kendall, Chief Executive Officer; and John Maxwell, Chief Financial Officer, who are going to provide an overview of recent business developments and performance in Q2 of this year. Additional members of our leadership team will be available for the Q&A at the end of the call. In total, we expect today's call to last approximately 60 minutes.

As a reminder, our remarks today correspond

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot